Viemed Healthcare Inc. (VMD) reported fourth-quarter 2025 results showing healthy top-line growth and expanding profitability. Total revenue was $76.2 million, up 25.5% year-over-year, supported by stronger gross margins and improved operating leverage.
Cost of sales increased alongside revenue, rising to $32.1 million, a 30.6% year-over-year increase that reflects higher volume and related costs.
Cash flow and balance-sheet items highlighted continued operating cash generation and modest investment activity.
Against analyst expectations, diluted EPS of $0.14 topped the estimate of $0.13, while revenue of $76.2 million came in below the estimate of $78.5 million. The stock moved approximately 1.98% since market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Viemed Healthcare Inc. Hedge Fund Activity
We have seen 60 institutional investors add shares of Viemed Healthcare Inc. stock to their portfolio, and 68 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP removed 1,546,010 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,497,407
- AMERIPRISE FINANCIAL INC added 697,866 shares (+558.5%) to their portfolio in Q4 2025, for an estimated $5,185,144
- PERRITT CAPITAL MANAGEMENT INC removed 599,759 shares (-82.7%) from their portfolio in Q3 2025, for an estimated $4,072,363
- KENT LAKE PR LLC removed 479,605 shares (-40.7%) from their portfolio in Q3 2025, for an estimated $3,256,517
- THRIVENT FINANCIAL FOR LUTHERANS removed 384,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,853,120
- JBF CAPITAL, INC. removed 252,317 shares (-85.3%) from their portfolio in Q4 2025, for an estimated $1,874,715
- RUSSELL INVESTMENTS GROUP, LTD. removed 208,568 shares (-95.3%) from their portfolio in Q4 2025, for an estimated $1,549,660
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
